Product Information
CEFAZOLIN 1 GM VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.0703 per EA under NDC 63323023710. Its NADAC has been published 258 times since Nov 28, 2013.
FDA first approved this application on Oct 22, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/3mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323023710
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
CEFAZOLIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065303FDA Approved
10/22/2008
TE Code
AP
On Market Since
7/15/2011
Pharmacological Classes
Price Statistics
The NADAC for CEFAZOLIN 1 GM VIAL has been published 258 times since Nov 28, 2013, and over the history we have for it it has risen 44.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0703 per EA |
|---|---|
| All-time high | $3.4547 (Aug 13, 2014) |
| All-time low | $0.6461 (Jun 17, 2015) |
| 52-week high | $1.0703 |
| 52-week low | $0.9547 |
| Median price | $0.9810 |
| Average price | $0.9579 |
| Largest weekly change | +300.2% (Jul 23, 2014) |
| Weeks tracked | 258 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CEFAZOLIN SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CEFAZOLIN SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFAZOLIN 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFAZOLIN 1 GM VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.0703 per EA (NDC 63323023710), effective Sep 30, 2026.
How has the price of CEFAZOLIN 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFAZOLIN 1 GM VIAL has risen 44.7%. It has been tracked across 258 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFAZOLIN 1 GM VIAL?
Since Nov 28, 2013, the NADAC for CEFAZOLIN 1 GM VIAL has ranged from a low of $0.6461 (Jun 17, 2015) to a high of $3.4547 (Aug 13, 2014), with a median of $0.9810 per EA.
Are there cheaper alternatives to CEFAZOLIN 1 GM VIAL?
No other NADAC-published product currently shares the active ingredient and strength of CEFAZOLIN 1 GM VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEFAZOLIN 1 GM VIAL?
CEFAZOLIN 1 GM VIAL (NDC 63323023710) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.